FlandersBio on Twitter

Core for Life - a new European alliance in biomedical research: http://t.co/Hvv6P88kRt

Follow us on Twitter

Life Sciences Database

Databank Biowetenschappen

in het nederlands in english

FlandersBio offers an up-to-date life sciences database containing all the life sciences companies with biotech activity in Flanders, and all FlandersBio members. The guide provides easy and fast access to the local life sciences community.

FlandersBio beschikt over een geüpdate databank met een overzicht van de Vlaamse bedrijven met biotechactiviteit en alle FlandersBio-leden. De databank verleent een makkelijke en vlugge toegang tot de lokale biowetenschappen-gemeenschap.

Genzyme

Website: http://www.genzyme.be
Email:
Phone: +32 14 56 49 11
FlandersBio Member
More address details

Business Focus

Genzyme is a global biopharmaceutical company helping patients in more than 100 countries. Genzyme is Sanofi’s global center of excellence in rare diseases and multiple sclerosis (MS). In Geel, Belgium, Genzyme has a manufacturing facility to produce therapeutic protein products through cell culture. The main product is recombinant alpha-glucosidase, the enzyme replacement therapy for Pompe disease, a rare genetic, often fatal, disease of the muscle.

Tags

Company Profile

Genzyme's commitment to innovation continues today with research into novel approaches to genetic disease, heart disease, and other areas of unmet medical need. Genzyme employees in offices around the globe serve patients in over 100 countries.

Genzyme BVBA founded in 2001 located in Geel, a large manufacturing site for biopharmaceuticals (employees >530).

Science & Technology or Services

Genzyme has strong development programs using multiple technologies to genetic diseases, cardiovascular diseases, and immune diseases. In research and development, the company takes a pragmatic approach that gives freedom to apply diverse technologies to specific medical areas. These technologies include proteins, polymers, small molecules, biomaterials, cell therapy and gene therapy.

Product description

Personalized Genetic Health and Cardiovascular:

  • Enzyme replacement treatment for Type 1 Gaucher disease.
  • Enzyme replacement treatment for Fabry disease.
  • Enzyme replacement treatment for Mucopolysaccharidosis I (MPS I).
  • Enzyme replacement treatment for Pompe disease.

Alliances

Genzyme seeks strategic collaborations to expand its portfolio of commercialized products and services, to supplement its product pipeline, and to access complementary research, technology, and development capabilities. The company focuses on first-rate science and on opportunities that address well-defined patient populations with unmet or underserved medical need.

Some major partnerships:

  • Biomarin - enzyme replacement therapy for Mucopolysaccharidosis type I
  • Isis Pharmaceutical: Developing Mipomersen for high risk cardiovascular disease

More info

Address: Cipalstraat 8
2440 Geel
Belgium

Route: Via Google Maps
Website: http://www.genzyme.be

Phone: +32 14 56 49 11
Fax: +32 14 56 49 80
Foundation date: 1/2001
Email: luc.kupers@genzyme.com

Location on a Map

Sorry, to find this company's location on Google Maps, Javascript is required.

Become a Member

Discover the 13 reasons to become a FlandersBio member and join our extensive life sciences network.

Read more

Biotechstockmarket

Belgian biotech on Euronext

Belgian biotech on Euronext

FlandersBio Members

IMS Health WorldEscrow NV Rousselot arGEN-X Biogazelle Pauwels Consulting EUROGENTEC InvertTox ProManGINE Consulting Seuss Consulting Centrum voor Medische Innovatie (CMI) NXT-Dx Deloitte Biocartis Rescop ALTIUS Balans Laboratorium Janssen Infectious Diseases - Diagnostics Progeno ApaCondi trinean Field Fisher Waterhouse Galapagos Turnstone Communications Metatecta LifeTechLimburg Bird & Bird LifetecVision BIPP, BIP eProcurement Platform for Life Sciences

View all members

Life Sciences Map

Life Sciences Map

View Life Sciences Map

Back to top

Print